Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial

NCT02942407 is registered in ClinicalTrials.gov with Christopher Granger, MD as lead sponsor.

NCT NCT02942407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02942407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Lead sponsor
Christopher Granger, MD
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2016
Completion date
August 12, 2019
Enrollment
154 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, end stage renal disease